Blood Flow Dynamics after Photodynamic Therapy with Verteporfin in the RIF-1 Tumor
- 1 October 2003
- journal article
- Published by Radiation Research Society in Radiation Research
- Vol. 160 (4) , 452-459
- https://doi.org/10.1667/rr3059
Abstract
In the present study, the effects of photodynamic therapy (PDT) with verteporfin on tumor blood flow and tumor regrowth were compared as verteporfin distributed in different compartments within the RIF-1 tumor. Tissue distribution of verteporfin was examined by fluorescence microscopy, and blood flow measurements were taken with a laser Doppler system. It was found that, at 15 min after drug administration, when verteporfin was mainly confined within the vasculature, PDT induced a complete arrest of blood flow by 6 h after treatment. PDT treatment at a longer drug-light interval (3 h), which allowed the drug to diffuse to the tumor interstitium, caused significantly less flow decrease, only to 50% of the initial flow in 6 h. A histological study and Hoechst 33342 staining of functional tumor vasculature confirmed the primary vascular damage and the decrease in tumor perfusion. The regrowth rate of tumors treated with 15-min interval PDT was 64% of that of the control group. However, when tumors were treated with 3-h interval PDT, the regrowth rate was not significantly different from that of the control, indicating that only the 15-min interval PDT caused serious damage to the tumor vascular bed. These results support the hypothesis that temporal pharmacokinetic changes in the distribution of the photosensitizer between the tumor parenchyma and blood vessels can significantly alter the tumor target of PDT.Keywords
This publication has 18 references indexed in Scilit:
- Tumor Po2 changes during photodynamic therapy depend upon photosensitizer type and time after injectionComparative Biochemistry and Physiology Part A: Molecular & Integrative Physiology, 2002
- In Vivo NADH Fluorescence Monitoring as an Assay for Cellular Damage in Photodynamic Therapy¶Photochemistry and Photobiology, 2001
- Photodynamic therapy targeted to tumor-induced angiogenic vesselsCancer Letters, 2001
- Palliation of advanced esophageal carcinoma by photodynamic therapy and irradiationThe Annals of Thoracic Surgery, 2000
- Photodynamic Therapy With Verteporfin for Choroidal Neovascularization Caused by Age-related Macular DegenerationArchives of Ophthalmology (1950), 1999
- The role of photodynamic therapy in dermatologyClinical and Experimental Dermatology, 1999
- Analysis of acute vascular damage after photodynamic therapy using benzoporphyrin derivative (BPD)British Journal of Cancer, 1999
- Photodynamic TherapyJNCI Journal of the National Cancer Institute, 1998
- Superficial blood flow following photodynamic therapy of malignant non–melanoma skin tumours measured by laser Doppler perfusion imagingBritish Journal of Dermatology, 1997
- Biodistribution of tritiated benzoporphyrin derivative (3H-BPD-MA), a new potent photosensitizer, in normal and tumor-bearing miceJournal of Photochemistry and Photobiology B: Biology, 1990